跳至主要内容
临床试验/ISRCTN00788389
ISRCTN00788389已完成未知

A randomised controlled trial to determine the clinical and cost effectiveness of thulium laser transurethral vaporesection of the prostate (ThuVARP) versus transurethral resection of the prostate (TURP) in the National Health Service (NHS)

orth Bristol NHS Trust (UK)0 个研究点目标入组 410 人开始时间: 2013年9月20日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
410

研究概览

简要总结

2017 protocol in https://www.ncbi.nlm.nih.gov/pubmed/28412960 2020 results in https://pubmed.ncbi.nlm.nih.gov/32622397/ (added 06/07/2020) 2020 results in https://pubmed.ncbi.nlm.nih.gov/32901611/ (added 10/09/2020) 2020 cost-effectiveness analysis in https://pubmed.ncbi.nlm.nih.gov/32558178/ (added 08/02/2021)

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • Adult men over the age of 18 suitable for TURP, either in urinary retention or with bothersome lower urinary tract symptoms (LUTS), secondary to BPO.

排除标准

  • Patients with:
  • 1. Neurogenic lower urinary tract dysfunction (LUTS)
  • 2. Prostate cancer
  • 3. Previous prostate or urethral surgery
  • Added 08/12/2017:
  • 4. A PSA outside of the normal age-related range and who have not had prostate cancer excluded
  • 5. Men who are unable to give informed consent or complete trial documentation

研究者

发起方
orth Bristol NHS Trust (UK)

相似试验